Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09XOF
|
||||
Former ID |
DIB001002
|
||||
Drug Name |
NY-ESO-1 vaccine
|
||||
Synonyms |
Cancer vaccine (peptides), Ludwig Institute; NY-ESO-1b; NY-ESO-1 OLP-4; NY-ESO-1 peptide immunotherapy, Ludwig Institute; NY-ESO-1 vaccine (peptides); NY-ESO-1 DP4 peptide (157-170); NY-ESO-1 vaccine (peptides), Ludwig Institute
|
||||
Drug Type |
Vaccine
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [521703] | ||
Company |
Ludwig Institute for Cancer Research
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
N([C@H](C(=O)N)CS)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]<br />(NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC<br />(=O)[C@@H](N)CO)CC(C)C)CC(C)C)CCSC)Cc1c[nH]c2c1cccc2)[C<br />@@H](C)CC)[C@H](O)C)CCC(=O)N
|
||||
Target and Pathway | |||||
Target(s) | NY-ESO-1 | Target Info | [544008] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.